Although the research group using Lgr5-2A-CreERT mice claimed that Lgr5+ chief cells gave rise to cancer following high-dose-tamoxifen-induced injury and mutant Kras expression, Kras activation alone does not cause histological cancer, but instead metaplasia, as in other Kras models. The gene discussed is LGR5; the disease is cancer.